Senior Product Strategist, Premera Blue Cross
CEO & Co-Founder, Boulder Care
The addiction treatment industry is unfortunately lagging in delivering evidence-based care, resulting in high readmission rates and substantial economic impact ($442B annually from SUDs). Now, payers have the power to realign incentives and unlock higher-quality, cost-effective care that holds providers accountable. Premera Blue Cross is a leader in advancing such value-based arrangements, and its work with Boulder presents a new framework for addressing the SUD crisis.
You will learn about: